STOCK TITAN
  1. Home
  2. Sec-filings
  3. ICE
  4. [Form 4] Intercontinental Exchange, Inc. Insider Trading Activity

Planned stock sales by ICE (NYSE: ICE) executive total 11,303 shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Intercontinental Exchange, Inc. President, Fixed Income & Data, Christopher Scott Edmonds reported open-market sales of 11,303 shares of common stock on February 19, 2026, under a pre-approved Rule 10b5-1 trading plan effective as of February 20, 2025. Following these sales, his reported holdings in Table I aggregate 2,662 shares of common stock, plus 9,206 unvested RSUs and 2,398 performance-based RSUs that vest over three years in equal annual installments of 33.33%.

Positive

  • None.

Negative

  • None.
Insider Edmonds Christopher Scott
Role President, Fixed Income & Data
Sold 11,303 shs ($1.74M)
Type Security Shares Price Value
Sale Common Stock 4,750 $153.2135 $728K
Sale Common Stock 4,653 $153.9609 $716K
Sale Common Stock 1,700 $154.9074 $263K
Sale Common Stock 200 $155.715 $31K
Holdings After Transaction: Common Stock — 20,819 shares (Direct)
Footnotes (1)
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025. The price range for the aggregate amount sold by the direct holder is $152.58 - $153.56. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The price range for the aggregate amount sold by the direct holder is $153.58 - $154.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The price range for the aggregate amount sold by the direct holder is $154.58 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The price range for the aggregate amount sold by the direct holder is $155.62 - $155.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. The common stock number referred in Table I is an aggregate number and represents 2,662 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Edmonds Christopher Scott
(Last) (First) (Middle)
5660 NEW NORTHSIDE DRIVE
(Street)
ATLANTA GA 30328
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Fixed Income & Data
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/19/2026 S 4,750(1) D $153.2135(2) 20,819 D
Common Stock 02/19/2026 S 4,653(1) D $153.9609(3) 16,166 D
Common Stock 02/19/2026 S 1,700(1) D $154.9074(4) 14,466 D
Common Stock 02/19/2026 S 200(1) D $155.715(5) 14,266(6)(7)(8) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of February 20, 2025.
2. The price range for the aggregate amount sold by the direct holder is $152.58 - $153.56. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
3. The price range for the aggregate amount sold by the direct holder is $153.58 - $154.57. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
4. The price range for the aggregate amount sold by the direct holder is $154.58 - $155.25. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
5. The price range for the aggregate amount sold by the direct holder is $155.62 - $155.81. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
6. The common stock number referred in Table I is an aggregate number and represents 2,662 shares of common stock and 9,206 unvested restricted stock units ("RSUs"), and 2,398 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
7. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
8. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
/s/ Octavia N. Spencer, Attorney-in-fact 02/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did ICE executive Christopher Scott Edmonds report on this Form 4 for ICE?

Christopher Scott Edmonds reported selling 11,303 shares of Intercontinental Exchange common stock in open-market transactions on February 19, 2026. These trades were disclosed as sales of non-derivative common stock and are detailed across multiple transactions in the filing.

Were Christopher Scott Edmonds’ ICE stock sales under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected under a Rule 10b5-1 trading plan that was approved and became effective as of February 20, 2025. Such plans pre-schedule trades, helping separate them from day-to-day discretionary decisions.

How many Intercontinental Exchange shares did Edmonds sell and at what prices?

He sold a total of 11,303 shares of common stock. Individual transactions list prices such as $153.2135, $153.9609, $154.9074, and $155.7150, with footnotes giving broader price ranges between $152.58 and $155.81.

What ICE equity holdings does Christopher Scott Edmonds report after these transactions?

After the reported sales, the aggregate common stock number in Table I reflects 2,662 shares of common stock, 9,206 unvested RSUs, and 2,398 performance-based RSUs. These unvested awards represent potential future shares subject to vesting and performance conditions.

How do Edmonds’ ICE RSUs and PSUs vest according to the filing?

The filing explains that the RSUs and performance-based RSUs vest over a three-year period, with 33.33% of the units vesting each year. Additional footnotes describe separate TSR and EBITDA PSU awards whose satisfaction will be determined in 2027–2029.

What future dates are tied to ICE performance-based PSU awards for Edmonds?

For certain 2024, 2025 and 2026 TSR and EBITDA PSU grants, satisfaction and share delivery will be determined in February 2027, February 2028 and February 2029. Separate Deal Incentive PSUs reference determinations around December 2026–2028 with added vesting conditions.